93 related articles for article (PubMed ID: 31605628)
1. Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer.
Verma S; Bakshi D; Sharma V; Sharma I; Shah R; Bhat A; Bhat GR; Sharma B; Wakhloo A; Kaul S; Heer V; Bhat A; Abrol D; Verma V; Kumar R
Int J Gynaecol Obstet; 2020 Jan; 148(1):118-122. PubMed ID: 31605628
[TBL] [Abstract][Full Text] [Related]
2. Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.
Wang J; Wang Q; Wei B; Zhou Y; Qian Z; Gao Y; Chen X
BMC Med Genet; 2019 May; 20(1):72. PubMed ID: 31053115
[TBL] [Abstract][Full Text] [Related]
3.
Shah R; Sharma V; Singh H; Sharma I; Bhat GA; Shah IA; Iqbal B; Rafiq R; Nissa N; Muzaffar M; Rasool MT; Lone GN; Kaul S; Lone MM; Rai E; Dar NA; Sharma S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S156-S159. PubMed ID: 32880595
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of polymorphism rs10937405 of
Verma S; Bakshi D; Bhat GR; Bhat A; Shah R; Sharma B; Wakhloo A; Heer V; Chander G; Kumar R
J Cancer Res Ther; 2023; 19(2):214-217. PubMed ID: 37006060
[TBL] [Abstract][Full Text] [Related]
5. Genetic variant rs2494938 of LRFN2 gene is associated with non-small cell lung cancer risk in North-Indian population.
Bhat GR; Verma S; Bhat A; Shah R; Sethi I; Dar KA; Abrol D; Bhat A; Raina R; Kumar R
3 Biotech; 2020 Sep; 10(9):410. PubMed ID: 32904533
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants at 6p21.1 and 7p15.3 Identified by GWASs of multiple cancers and ovarian cancer risk: a case-control study in Han Chinese women.
Li DK; Han J; Liu JB; Jin GF; Qu JW; Zhu M; Wang YR; Jiang J; Ma HX
Asian Pac J Cancer Prev; 2014; 15(1):123-7. PubMed ID: 24528012
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
Gates MA; Tworoger SS; Terry KL; De Vivo I; Hunter DJ; Hankinson SE; Cramer DW
Int J Cancer; 2009 Feb; 124(3):729-33. PubMed ID: 18973230
[TBL] [Abstract][Full Text] [Related]
8. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
[TBL] [Abstract][Full Text] [Related]
9. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
10. Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.
Claus EB; Stowe M; Carter D
Breast Cancer Res Treat; 2003 Mar; 78(1):7-15. PubMed ID: 12611452
[TBL] [Abstract][Full Text] [Related]
11. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
[TBL] [Abstract][Full Text] [Related]
12. Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India.
Bhat GR; Bhat A; Verma S; Sethi I; Shah R; Sharma V; Dar KA; Abrol D; Kaneez S; Kaul S; Ganju R; Kumar R
BMC Cancer; 2019 May; 19(1):493. PubMed ID: 31126249
[TBL] [Abstract][Full Text] [Related]
13. Association of
Zhu D; Zhang H; Wang R; Liu X; Jiang Y; Feng T; Liu R; Zhang G
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160482
[No Abstract] [Full Text] [Related]
14. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.
Song H; Ramus SJ; Kjaer SK; DiCioccio RA; Chenevix-Trench G; Pearce CL; Hogdall E; Whittemore AS; McGuire V; Hogdall C; Blaakaer J; Wu AH; Van Den Berg DJ; Stram DO; Menon U; Gentry-Maharaj A; Jacobs IJ; Webb PM; Beesley J; Chen X; ; ; Rossing MA; Doherty JA; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Ness RB; Moysich K; Goode EL; Vierkant RA; Cunningham JM; Anderson S; Schildkraut JM; Berchuck A; Iversen ES; Moorman PG; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Anton-Culver H; Ziogas A; Brewster WR; Ponder BA; Easton DF; Gayther SA; Pharoah PD;
Hum Mol Genet; 2009 Jun; 18(12):2297-304. PubMed ID: 19304784
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
16. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract][Full Text] [Related]
17. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.
Webb PM; Hopper JL; Newman B; Chen X; Kelemen L; Giles GG; Southey MC; Chenevix-Trench G; Spurdle AB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):319-23. PubMed ID: 15734952
[TBL] [Abstract][Full Text] [Related]
18. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study.
Parazzini F; Negri E; La Vecchia C; Restelli C; Franceschi S
Am J Epidemiol; 1992 Jan; 135(1):35-40. PubMed ID: 1736658
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
20. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
